Advertisement
ENOV vs PHG
Which Stock Would AI Choose? Enovis Corporation (ENOV) vs. Koninklijke Philips N.V. (PHG) Stock Comparison
Key Takeaways
- Enovis Corporation (ENOV) operates in medical technology with a focus on orthopedic and rehabilitation solutions, while Koninklijke Philips N.V. (PHG) is a diversified health technology leader spanning diagnostics, imaging, and connected care.
- Recent market activity shows (ENOV) with modest year-to-date gains amid product launches and upcoming earnings, contrasting with (PHG)’s broader sector exposure and variable sentiment tied to global healthcare demand.
- Both stocks trade in the healthcare sector but differ in scale, with (ENOV) as a smaller-cap growth-oriented name and (PHG) offering established international operations and diversified revenue streams.
- Relative performance in recent weeks highlights (ENOV)’s sensitivity to U.S. procedural volumes and innovation catalysts, versus (PHG)’s exposure to regulatory and macroeconomic factors across multiple regions.
- Sector positioning places both amid ongoing healthcare innovation trends, though (ENOV) emphasizes specialized surgical and rehab products while (PHG) integrates digital health and monitoring platforms.
- Market sentiment reflects ongoing analyst coverage for (ENOV) around free cash flow and product pipelines, balanced against (PHG)’s emphasis on operational efficiency and portfolio optimization.
Introduction
Enovis Corporation (ENOV) and Koninklijke Philips N.V. (PHG) represent two distinct profiles within the healthcare technology space. This comparison examines their business models, recent stock behavior, and key differentiators to assist investors and traders evaluating relative positioning in the current market environment. The analysis draws on observable factors such as sector exposure, performance trends, and operational developments, making it relevant for those assessing mid-cap growth opportunities alongside established multinational healthcare players.
Enovis Corporation (ENOV) Overview and Recent Performance
Enovis Corporation (ENOV) develops clinically differentiated medical technology solutions, primarily in orthopedics, surgical reconstruction, and rehabilitation. The company focuses on products that improve patient outcomes in areas such as joint replacement, sports medicine, and foot and ankle care. Recent market activity has featured continued emphasis on product innovation, including the launch of a next-generation veterinary laser therapy system and a hybrid scoliosis brace designed for improved wearability. In recent weeks, the stock has shown modest price fluctuations around the $27 level amid broader healthcare sector movements and anticipation of second-quarter 2026 results. Sentiment has been influenced by prior quarterly beats on revenue and adjusted earnings, alongside analyst commentary on free cash flow conversion and pipeline potential. Year-to-date returns remain limited relative to broader market benchmarks, reflecting the company’s smaller market capitalization and focus on specialized procedural volumes.
Koninklijke Philips N.V. (PHG) Overview and Recent Performance
Koninklijke Philips N.V. (PHG) is a global health technology company offering solutions in diagnostic imaging, image-guided therapy, monitoring, and connected care. Its portfolio spans hospital and home settings, with additional presence in personal health products. Recent market activity has reflected ongoing integration of digital health capabilities and operational adjustments across international markets. The stock has experienced variable trading patterns influenced by healthcare utilization trends and macroeconomic factors affecting capital equipment spending. In recent weeks, performance has aligned with sector peers amid mixed global demand signals, with emphasis on efficiency initiatives and portfolio refinement. Broader timeframe references show resilience in core diagnostic and monitoring segments, though exposure to regulatory environments and supply chain dynamics has contributed to sentiment shifts. The company’s larger scale and diversified revenue base distinguish its market behavior from more specialized peers.
Trending AI Robots
Tickeron maintains a curated Trending AI Robots section that highlights select AI trading bots from its extensive library of hundreds of bots capable of trading thousands of different tickers. Only those demonstrating strong suitability for prevailing market conditions, consistent historical metrics, and alignment with current volatility and trend environments earn placement in this section. Available bots span a wide range of trading styles, strategies, timeframes, performance statistics, and ticker sets, with many reporting win rates in the 60-75% range and varying drawdown profiles depending on the approach. This diversity allows users to explore options suited to different risk tolerances and market views. Review the full selection on the Trending AI Robots page for detailed statistics and configuration details.
Head-to-Head Comparison
Enovis Corporation (ENOV) and Koninklijke Philips N.V. (PHG) operate in overlapping healthcare technology spaces but differ markedly in scale and focus. (ENOV) centers on specialized orthopedic and rehabilitation devices with growth tied to procedural volumes and new product adoption, whereas (PHG) delivers a broader array of imaging, monitoring, and digital health platforms serving hospitals and consumers globally. Recent momentum for (ENOV) has centered on U.S.-centric innovation catalysts and quarterly execution, while (PHG) contends with international regulatory and demand variability. Risk factors for (ENOV) include concentration in surgical markets and smaller capitalization volatility; (PHG) faces exposure to capital spending cycles and currency fluctuations. Sector sentiment currently favors companies demonstrating clear free cash flow visibility, an area where both have drawn analyst attention but through different operational lenses. Trade-offs include (ENOV)’s higher potential sensitivity to medical device reimbursement trends versus (PHG)’s more stable but slower-moving multinational footprint.
Tickeron AI Verdict
Based on observable trend consistency, stability metrics, and relative positioning in recent market activity, Tickeron’s AI would currently assign a probabilistic preference to Koninklijke Philips N.V. (PHG) for its diversified revenue base and established global platform, which may offer more consistent positioning amid sector fluctuations. Enovis Corporation (ENOV) presents compelling catalysts around product launches and earnings visibility but carries higher volatility typical of smaller specialized names. This assessment relies on current data patterns rather than forward projections.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Buy and PHG is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- PHG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 6 TA indicator(s) are bullish while PHG’s TA Score has 4 bullish TA indicator(s).
- ENOV’s TA Score: 6 bullish, 4 bearish.
- PHG’s TA Score: 4 bullish, 6 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а +7.84% price change this week, while PHG (@Medical/Nursing Services) price change was +0.50% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.
Reported Earning Dates
ENOV is expected to report earnings on Aug 06, 2026.
PHG is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Medical/Nursing Services (+2.50% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ENOV | PHG | ENOV / PHG | |
| Capitalization | 1.68B | 25.6B | 7% |
| EBITDA | -770.33M | 3.01B | -26% |
| Gain YTD | 9.422 | 0.904 | 1,042% |
| P/E Ratio | N/A | 20.12 | - |
| Revenue | 2.28B | 17.7B | 13% |
| Total Cash | 33.1M | 1.79B | 2% |
| Total Debt | 1.41B | 7.47B | 19% |
ENOV | PHG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 71 | |
PRICE GROWTH RATING 1..100 | 36 | 57 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (2) in the Electronic Production Equipment industry is significantly better than the same rating for ENOV (82) in the Industrial Machinery industry. This means that PHG’s stock grew significantly faster than ENOV’s over the last 12 months.
PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that PHG’s stock grew similarly to ENOV’s over the last 12 months.
PHG's SMR Rating (71) in the Electronic Production Equipment industry is in the same range as ENOV (99) in the Industrial Machinery industry. This means that PHG’s stock grew similarly to ENOV’s over the last 12 months.
ENOV's Price Growth Rating (36) in the Industrial Machinery industry is in the same range as PHG (57) in the Electronic Production Equipment industry. This means that ENOV’s stock grew similarly to PHG’s over the last 12 months.
ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that ENOV’s stock grew similarly to PHG’s over the last 12 months.
| ENOV | PHG | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 67% | 4 days ago 87% |
| Stochastic ODDS (%) | 4 days ago 69% | 4 days ago 58% |
| Momentum ODDS (%) | 4 days ago 65% | 4 days ago 61% |
| MACD ODDS (%) | 4 days ago 67% | 4 days ago 60% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 61% |
| TrendMonth ODDS (%) | 4 days ago 61% | 4 days ago 59% |
| Advances ODDS (%) | 6 days ago 61% | 5 days ago 66% |
| Declines ODDS (%) | 4 days ago 78% | 12 days ago 62% |
| BollingerBands ODDS (%) | 4 days ago 76% | 4 days ago 70% |
| Aroon ODDS (%) | 4 days ago 54% | 4 days ago 61% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WISE | 34.27 | 0.70 | +2.08% |
| Themes Generative Artificial Int ETF | |||
| TESL | 12.10 | 0.21 | +1.78% |
| Simplify Volt TSLA Revolution ETF | |||
| IMTG | 48.80 | N/A | N/A |
| Invesco Agency MBS ETF | |||
| SPRE | 21.47 | -0.09 | -0.42% |
| SP Funds S&P Global REIT Sharia ETF | |||
| EDIV | 41.40 | -0.29 | -0.70% |
| State Street® SPDR® S&P Em Mkts Div ETF | |||
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -0.51% | ||
| FELE - ENOV | 56% Loosely correlated | +1.21% | ||
| CNMD - ENOV | 56% Loosely correlated | -1.45% | ||
| DOV - ENOV | 55% Loosely correlated | +0.27% | ||
| PH - ENOV | 53% Loosely correlated | +1.43% | ||
| ITT - ENOV | 52% Loosely correlated | +1.54% | ||
More | ||||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with GEHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then GEHC could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | -0.53% | ||
| GEHC - PHG | 51% Loosely correlated | -2.75% | ||
| ALC - PHG | 49% Loosely correlated | -0.96% | ||
| ENOV - PHG | 43% Loosely correlated | -0.51% | ||
| STE - PHG | 42% Loosely correlated | -1.22% | ||
| BAX - PHG | 40% Loosely correlated | -2.21% | ||
More | ||||